Aptose Biosciences Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Right-of-use Assets (Tables)

9 Months Ended

Sep. 30, 2021

	Nine months ended September 30, 2021			Year ended December 31, 2020
Right-of-use assets, beginning of period	$	1,848		$	1,837
Additions to right-of-use assets		7			11
Right-of-use assets, end of period		1,855			1,848
Accumulated amortization		(1,276	)		(923	)
Right-of use assets, NBV	$	579		$	925